Ob/Gyn: Page 43

US-based minimally invasive treatments prove feasible for uterine fibroids
By Shalmali Pal
When it comes to the ultrasound-based treatment of uterine fibroids, clinicians should target patients whose benign tumors are not too big or not too small, according to two new studies. Researchers from Italy found that that percutaneous sonography-guided radiofrequency thermal ablation (RFA) was particularly adept at shrinking medium-sized fibroids, while a Japanese team found that MR-guided focused ultrasound (MRgFUS) surgery was an optimal therapy option for fibroids with specific characteristics on preoperative imaging.
November 19, 2007
2007 11 19 15 38 54 706
Toshiba America Medical Systems
By Cheryl Hall Harris, R.N.
(Booth 7130) Look for Tustin, CA-based Toshiba America Medical Systems to launch 4D volume imaging applications at the 2007 RSNA show, along with a microconvex transducer and an upgrade to its Xario XG scanner.
November 4, 2007
2007 11 02 12 22 12 706
Shimadzu Medical Systems North America
By Cheryl Hall Harris, R.N.
(Booth 4739) Shimadzu Medical Systems North America of Torrance, CA, will highlight the SDU-1100 and SDU-2200 ultrasound scanners as works-in-progress in the company's RSNA booth.
November 4, 2007
DatCard Systems
By Cheryl Hall Harris, R.N.
(Booth 8528) DatCard Systems of Irvine, CA, will use its RSNA appearance to exhibit BabySmart, an educational CD product for use with referred obstetric patients.
November 4, 2007
Sanarus to feature new version of Visica at RSNA
By AuntMinnie.com staff writers
Sanarus Medical of Pleasanton, CA, has announced that it plans to highlight its Visica 2 treatment system at the upcoming 2007 RSNA meeting in Chicago.
October 30, 2007
ACRIN, GOG launches cervical cancer study
By AuntMinnie.com staff writers
The American College of Radiology Imaging Network (ACRIN) and the Gynecologic Oncology Group (GOG) have begun a study to evaluate two imaging modalities for identifying pelvic and abdominal lymph node metastases in patients with locoregionally advanced cervical cancer.
October 8, 2007
SUV on FDG-PET can predict cervical cancer prognosis
By Shalmali Pal
Historically, age and histology, as well as tumor volume and stage, have been used to predict patient outcome and overall survival for cervical cancer. But a multidisciplinary group from St. Louis-based Washington University School of Medicine has recommended the adoption of tumor uptake on FDG-PET imaging as a better biomarker for outcome and survival.
September 18, 2007
Pilot study shows link between FDG uptake and biomarkers of cervical cancer
By Shalmali Pal
SAN FRANCISCO - Imaging and genetic profiling can work hand in hand to assess tumor aggression in cervical cancer, according to a presentation last week at the Translation Research in Radiation Oncology and Radiology meeting, sponsored by the American Society for Therapeutic Radiology and Oncology (ASTRO).
September 10, 2007
2007 09 10 11 43 58 706
Fetal anatomic survey yields unexpected anomalies in antepartum US
By Erik L. Ridley
Performing fetal anatomic surveys on follow-up antepartum sonograms can contribute to the discovery of unforeseen fetal anomalies, according to an article published in the September issue of the Journal of Ultrasound in Medicine.
August 23, 2007
U.K. expert questions routine Down syndrome screening
By AuntMinnie.com staff writers
The usefulness of fetal nuchal thickness as a technique to diagnose Down syndrome in obstetric ultrasound is overstated, according to a piece published in Ultrasound, the Journal of the British Medical Ultrasound Society.
August 15, 2007
GA-oriented morphology boosts fetal US malformation workup
By Erik L. Ridley
Incorporating gestational age (GA)-oriented morphology in biometry data could significantly increase the yield for ultrasound scanning of fetal malformations during the 6-16 weeks gestational age, according to research from the Ironfan-International Registry of Fetal Anomalies at Columbia University Medical Center in New York City.
August 8, 2007
2007 08 08 15 32 43 706
PET changes oncology management, study shows
By Wayne Forrest
A multisite study in Australia has found that PET results can change treatment plans for cancer patients, as the modality provides more information on the extent, recurrence, and progression of the disease. The Australian PET Data Collection Project has collected data on whether the modality changed the management of patients with different types of cancer, such as ovarian cancer, metastatic melanoma, and colorectral cancer.
July 18, 2007
Previous Page
Page 43 of 63
Next Page